Capula Management LTD Elanco Animal Health Inc Transaction History

Capula Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$9.81 - $12.62 $251,332 - $323,324	-25,620 Reduced 39.76%	38,820 $436,000
Q2 2023 Aug 14, 2023	BUY	$8.08 - $10.37 $520,675 - $668,242	64,440 New	64,440 $648,000
Q4 2021 Feb 14, 2022	SELL	$27.74 - $34.09 $367,305 - $451,385	-13,241 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$29.2 - $36.72 $29,083 - $36,573	996 Added 8.13%	13,241 $422,000
Q2 2021 Aug 13, 2021	BUY	$28.76 - $35.98 $352,166 - $440,575	12,245 New	12,245 $425,000
Q1 2021 May 14, 2021	SELL	$27.85 - $34.49 $130,059 - $161,068	-4,670 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$27.53 - $33.79 $128,565 - $157,799	4,670 New	4,670 $143,000

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.